BAP-65 Score for Acute Exacerbation of COPD
ورودیهای بالینی بیمار
حداقل ۴۱ — حداکثر ۱۲۰ • واحد: years
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Class I0–0
- Class II0–0
- Class III1–1
- Class IV2–2
Clinical Decision Pathway
Clinical Decision Pathway & Next Steps
Respiratory & Pneumonia — بیماریهای تنفسی، پنومونی و COPD
Clinical Rationale:
Stratify community-acquired pneumonia with CURB-65 and PSI/PORT; monitor ROX during high-flow oxygen for intubation avoidance, and guide acute COPD exacerbation with BAP-65, DECAF, and GOLD criteria.
ROX Index for Intubation after HFNC
شاخص ROX (لولهگذاری در کانولای پرجریان)
Recommended Clinical Next Steps:
DECAF Score for Acute Exacerbation of COPD
امتیاز DECAF (مرگومیر بستری در COPD)
Why next: In-hospital mortality prediction in acute COPDGlobal Initiative for Obstructive Lung Disease (GOLD) Criteria for COPD
معیارهای GOLD برای شدت COPD
Why next: Airflow limitation severity staging by post-BD FEV1
The BAP-65 Score for Acute Exacerbation of COPD calculator is designed for bedside predicting mortality in acute COPD exacerbation using BUN, Altered mental status, Pulse rate, and age ≥65 years in clinical practice. The resulting score directly guides clinician decision-making regarding determining appropriate admission level.
Clinical Guidelines & Evidence
Predicts mortality in acute COPD exacerbation using BUN, Altered mental status, Pulse rate, and age ≥65 years
Clinical Indication
The BAP-65 Score for Acute Exacerbation of COPD is indicated for bedside clinical practice to support Predicts mortality in acute COPD exacerbation using BUN, Altered mental status, Pulse rate, and age ≥65 years. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with community-acquired pneumonia, COPD exacerbations, acute asthma, pulmonary embolism, or acute respiratory distress. Clinical application is indicated across Respiratory care units, emergency pulmonary triage, sleep clinics, and medical floors.
Limitations & Contraindications
Peripheral pulse oximetry loses reliability in hypoperfusion, severe vasoconstriction, methemoglobinemia, or carboxyhemoglobinemia.
Clinical Pearls & Action Plan
Synchronous evaluation of arterial blood gas (PaO2/FiO2), mechanics of breathing, and clinical trajectory guides respiratory failure management.
BAP-65 = BUN ≥25 mg/dL (1 point) + Altered Mental Status (1 point) + Pulse ≥109/min (1 point) + Age ≥65 years (1 point)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| bun | string | Yes | Blood Urea Nitrogen (BUN) ≥25 mg/dL (8.9 mmol/L) |
| altered_mental_status | string | Yes | Altered Mental Status - Initial Glasgow Coma Scale <14, or disorientation, stupor, or coma |
| pulse | string | Yes | Pulse ≥109 beats/min |
| age | integer | Yes | Patient age in years(years) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–0 | Class I | 0 points, age <65 years |
| 0–0 | Class II | 0 points, age ≥65 years |
| 1–1 | Class III | 1 point, any age |
| 2–2 | Class IV | 2 points, any age |
| 3–3 | Class V | 3 points, any age |
Evidence-Based References (EBM)
- Tabak YP, Sun X, Johannes RS, Gupta V, Shorr AF. Mortality and need for mechanical ventilation in acute exacerbations of chronic obstructive pulmonary disease: development and validation of a simple risk score. Arch Intern Med. 2009 Sep 28;169(17):1595-602. doi: 10.1001/archinternmed.2009.270. PMID: 19786679.DOI: 10.1001/archinternmed.2009.270PMID: 19786679
- Shorr AF, Sun X, Johannes RS, Yaitanes A, Tabak YP. Validation of a novel risk score for severity of illness in acute exacerbations of COPD. Chest. 2011 Nov;140(5):1177-1183. doi: 10.1378/chest.10-3035. Epub 2011 Apr 28. PMID: 21527510.DOI: 10.1378/chest.10-3035PMID: 21527510